Pharmaceutical Preparations · NJ · CIK 911216
Developing first-in-class medicines modulating the melanocortin receptor system for unmet medical needs
Comparable business profile · signals at a glance
In the 90 days to Dec 24, 2025: 1 sold $9K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 24, 2025 | Wills Stephen TExecutive VP and CFO/COO | Sell | 565 | $16.74 | $9K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.